4CPS-089 All-oral direct-acting antiviral combination therapy: chronic hepatitis c treatment after unsuccessful therapy with daas agents

por Gonzalez, M Madrid, Moreno-Garcia, M, Castellano-Herrador, JJ, Ramis-Riera, X, del Olmo-Revuelto, A
Publicado en Eur J Hosp Pharm (2018)

4CPS-084 Identification of patient candidates to switch from tenofovir/emtricitabine to abacavir/lamivudine antiretroviral therapy: economic saving

por Moreno-Garcia, M, Castellano-Herrador, JJ, Madrid-Gonzalez, M, Ramis-Riera, X, Santos-Pérez, M, Prada-Lobato, J, Rodriguez-Barbero, J
Publicado en Eur J Hosp Pharm (2018)